![](/img/cover-not-exists.png)
Urinary asymmetric dimethylarginine (ADMA) is a predictor of mortality risk in patients with coronary artery disease
Christian Wolf, Johan M. Lorenzen, Sylvia Stein, Dimitrios Tsikas, Stefan Störk, Frank Weidemann, Georg Ertl, Stefan D. Anker, Johann Bauersachs, Thomas ThumVolume:
156
Year:
2012
Language:
english
DOI:
10.1016/j.ijcard.2010.11.003
File:
PDF, 408 KB
english, 2012